Ocular Surface Disease

Investigators find that long-term ocular complications require further observation.

Cynthia Matossian, MD, FACS, ABES, takes a look at the recent, sudden change in low-payment reimbursement by Medicare Administrative Contractors for LipFlow and MGD procedure codes.

Researchers consider frequency and factors in etiology of complication

Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) has the potential to treat patients with varying degrees of severity of acquired ptosis compared with vehicle.

Unilateral ptosis can be the first symptom related to other causes that are traumatic, myogenic, neurogenic, or mechanical in nature.

Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair

Investigators searched PubMed over the past 2 decades for clinical trials on eyelid ptosis using the terms blepharoptosis or upper eyelid ptosis or eyelid ptosis” and the filters “randomized controlled trial (RCT), clinical trial, and humans.”

Symptomatic, psychosocial burdens in participants .

Researchers conducted a retrospective observational study to assess the corneal refractive changes induced by surgery to correct ptosis using Fourier harmonic analysis.

A study suggests that for the general population, evaluation for blepharoptosis should be done at 66 years of age, or at 63 and 70 years for males and females, separately.

CAM’s regenerative healing means long-term relief and fewer visits to clinic.

Tool for quantifying measures may predict outcomes for patients.

According to Oculus, its Myopia Master saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via an inbuilt display.

The company is evaluating topical cyclosporine to treat the signs and symptoms of dry eye disease.

According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.

Most patients with allergic disorder are children, adolescents, or young adults.

Perhaps the most important consideration is understanding the neuromuscular pathway that retracts and protracts the eyelid.

Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.

Elizabeth Yeu, MD, shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of TP03 for the treatment of patients diagnosed with Demodex blepharitis.

Jonathan D. Shader, DO, CPA, presents a case study involving an uncommon cause of posterior-intermediate uveitis: the black ink used to create a tattoo.

Cynthia Matossian, MD, FACS, provides an overview on dry eye flares, including causes, symptoms, and her experience with dry eye flare patients.

AAO develops task forces to evaluate academy, review outcomes in ophthalmology.

Santen Inc. announced Thursday that the U.S. FDA has approved Verkazia (cyclosporine ophthalmic emulsion) 0.1% eye drops to treat vernal keratoconjunctivitis (VKC).

Patients who are members of racial and ethnic minority groups present clinically with worse objective measures of dry eye than patients who do not belong to these groups, new research shows.

According to investigators, the system has been shown to almost triple the number of people with eye problems attending primary care, as well as increasing appropriate uptake of hospital services.